title: Ability to culture resectable non-small cell lung carcinomas is correlated with recurrence.
abstract: Present clinicopathologic staging of non-small cell lung cancer is limited in its ability to provide more than a general prognostic estimate in patients with lung cancer who have resectable disease. This study was performed to identify whether the ability to adapt tumor tissue from resectable (stage I to IIIa) non-small cell lung cancer was associated with a poorer prognosis and an increased risk for early tumor recurrence. We attempted to culture a tumor specimen obtained from 90 patients with resectable non-small cell lung cancer. We used a culture medium conditioned by exposure to the lung cancer cell line A549-1, a known producer of autocrine lung cancer growth factors, and provided tumor colony scaffolding using a feeder layer of inactivated fibroblasts, and found these measures improved tumor culture yields. Twenty-two cell lines were obtained, a success rate of 24.4%. Tumor recurrences were more common (79%) among the culture-positive patients than among the culture-negative patients (37.5%; p < 0.002). For all patients, survival at 19 months in the culture-positive patients was 50.0%, compared with 83.6% in the culture-negative patients (p < 0.005). The median survival for the culture-positive patients was 15 months, versus 21.7 months for the culture-negative patients (p < 0.004). The establishment of a culture was a predictor of shortened survival for patients with stage I disease. In patients with stage I disease, survival at 19 months was 54.5% for the culture-positive patients, versus 89% for the culture-negative patients (p < 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Pharmacology, University of Pittsburgh, Pennsylvania 15261.
authors.forename: J M
authors.initials: JM
authors.lastname: Siegfried
authors.forename: A L
authors.initials: AL
authors.lastname: Davis
authors.forename: J R
authors.initials: JR
authors.lastname: Testa
authors.forename: J D
authors.initials: JD
authors.lastname: Hunt
authors.forename: R J
authors.initials: RJ
authors.lastname: Keenan
authors.forename: S A
authors.initials: SA
authors.lastname: Yousem
authors.forename: P S
authors.initials: PS
authors.lastname: Ritter
authors.forename: P F
authors.initials: PF
authors.lastname: Ferson
authors.forename: R J
authors.initials: RJ
authors.lastname: Landreneau
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology* / Q000556:secondary / Q000601:surgery; D002461:Cell Line, Transformed; D017077:Culture Media, Conditioned; D046508:Culture Techniques; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D008207:Lymphatic Metastasis; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors; D014407:Tumor Cells, Cultured
chemical_list: D017077:Culture Media, Conditioned